Emcure Pharmaceuticals to raise ₹1,100 crore via fresh issue; Bain Capital to sell stake via IPO

Pune-based Emcure Pharmaceuticals has come forth again to publicly list its shares on exchanges.
In 2014, the company had attempted to hit the stock exchanges, but reportedly did not pursue it after Bain Capital invested about ₹226 crore, by which it was able to meet its immediate liquidity needs.
Now the initial public offering (IPO) comprises a fresh issue of ₹1,100 crore and an offer for sale of up to 1.81 crore equity shares that include promoters — Satish Mehta selling up to 20.30 lakh equity shares and Sunil Mehta selling up to 2.50 lakh equity shares. Other selling shareholders include private equity investor Bain Capital, as well as certain individual shareholders. Media reports say the IPO size might be ₹4,000 crore including fresh issue and offer for sale.

Leave a Reply

Your email address will not be published. Required fields are marked *

Emcure Pharmaceuticals to raise ₹1,100 crore via fresh issue; Bain Capital to sell stake via IPO

Pune-based Emcure Pharmaceuticals has come forth again to publicly list its shares on exchanges.
In 2014, the company had attempted to hit the stock exchanges, but reportedly did not pursue it after Bain Capital invested about ₹226 crore, by which it was able to meet its immediate liquidity needs

Leave a Reply

Your email address will not be published. Required fields are marked *

Emcure Pharmaceuticals to raise ₹1,100 crore via fresh issue; Bain Capital to sell stake via IPO

Pune-based Emcure Pharmaceuticals has come forth again to publicly list its shares on exchanges.
In 2014, the company had attempted to hit the stock exchanges, but reportedly did not pursue it after Bain Capital invested about ₹226 crore, by which it was able to meet its immediate liquidity needs.

Leave a Reply

Your email address will not be published. Required fields are marked *

Emcure Pharmaceuticals to raise ₹1,100 crore via fresh issue; Bain Capital to sell stake via IPO

Pune-based Emcure Pharmaceuticals has come forth again to publicly list its shares on exchanges.
In 2014, the company had attempted to hit the stock exchanges, but reportedly did not pursue it after Bain Capital invested about ₹226 crore, by which it was able to meet its immediate liquidity needs.

Leave a Reply

Your email address will not be published. Required fields are marked *